Pancreatic Cancer Research

ResearcherChongqing UniversityActive in the last 2 years

Junfeng Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0009-2097-7250; OpenAlex author ID A5107845748. Sources: OpenAlex.

Their work

Papers
15 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
49
Papers, trials and grants by year

2014: 3 papers · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: 2 papers · 2020: 1 paper · 2021: 2 papers · 2022: 1 paper · 2023: none · 2024: 2 papers · 2025: 1 paper · 2026: 1 paper

Papers 15

  1. A peritumoral microenvironment engaged by Reg-EXTL3 axis fosters nerve-cancer interactions in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.neuron.2026.03.039↗
  2. Atypical endoscopic ultrasound findings in pancreatic ductal adenocarcinoma challenging traditional diagnostic criteria. Co-author DOI 10.1016/j.gie.2025.04.016↗
  3. Identifying suitable candidates for pancreaticoduodenectomy with extended lymphadenectomy for pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.hpb.2024.07.405↗
  4. The lncRNA LINC01605 promotes the progression of pancreatic ductal adenocarcinoma by activating the mTOR signaling pathway. Co-author DOI 10.1186/s12935-024-03440-z↗
  5. HOXA10 promote pancreatic cancer progression via directly activating canonical NF-κB signaling pathway. Co-author DOI 10.1093/carcin/bgac042↗
  6. SF3B1 mutation in pancreatic cancer contributes to aerobic glycolysis and tumor growth through a PP2A-c-Myc axis. Co-author DOI 10.1002/1878-0261.12970↗
  7. CD74 promotes perineural invasion of cancer cells and mediates neuroplasticity via the AKT/EGR-1/GDNF axis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2021.03.016↗
  8. The lncRNA RUNX1-IT1 regulates C-FOS transcription by interacting with RUNX1 in the process of pancreatic cancer proliferation, migration and invasion. First author DOI 10.1038/s41419-020-2617-7↗
  9. Transcription factor NFAT5 contributes to the glycolytic phenotype rewiring and pancreatic cancer progression via transcription of PGK1. Co-author DOI 10.1038/s41419-019-2072-5↗
  10. SFRP4 is a prognostic marker and correlated with Treg cell infiltration in pancreatic ductal adenocarcinoma. Co-author PMID 30906634↗
  11. Analysis of long non-coding RNA expression profiles in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/srep33535↗
  12. High expression of DDR1 is associated with the poor prognosis in Chinese patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s13046-015-0202-1↗
  13. Long non-coding RNAs expressed in pancreatic ductal adenocarcinoma and lncRNA BC008363 an independent prognostic factor in PDAC. Co-author DOI 10.1016/j.pan.2014.07.013↗
  14. Effect of CD74 on the prognosis of patients with resectable pancreatic cancer. Co-author DOI 10.1016/s1499-3872(14)60011-4↗
  15. MicroRNAs in stool samples as potential screening biomarkers for pancreatic ductal adenocarcinoma cancer. Co-author PMID 25520858↗

Closest collaborators

The 25 strongest of 49 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yongwei Sun · 11 shared papers, 2014–2024 · strength 0.97
  2. Rong Hua · 10 shared papers, 2014–2024 · strength 0.82
  3. Yan‐Miao Huo · 9 shared papers, 2014–2024 · strength 0.77
  4. Jian‐Yu Yang · 8 shared papers, 2014–2024 · strength 0.72
  5. Minwei Yang · 7 shared papers, 2015–2022 · strength 0.65
  6. Tao Zhang · 2 shared papers, 2024–2025 · strength 0.52
  7. Xueliang Fu · 6 shared papers, 2015–2021 · strength 0.49
  8. Shu‐Heng Jiang · 3 shared papers, 2021–2026 · strength 0.43
  9. Wei Liu · 4 shared papers, 2014–2024 · strength 0.39
  10. Yu-Heng Zhu · 2 shared papers, 2024–2026 · strength 0.38
  11. Hong‐Fei Yao · 2 shared papers, 2024–2026 · strength 0.38
  12. Dejun Liu · 4 shared papers, 2014–2021 · strength 0.30
  13. Jianyou Gu · 2 shared papers, 2020–2024 · strength 0.29
  14. Huaizhi Wang · 2 shared papers, 2020–2024 · strength 0.29
  15. Dejun Liu · 2 shared papers, 2019–2026 · strength 0.27
  16. Yongsheng Jiang · 2 shared papers, 2019–2022 · strength 0.24
  17. Jiang Chongyi · 1 shared paper, 2026 · strength 0.20
  18. Luju Jiang · 1 shared paper, 2026 · strength 0.20
  19. Hui Li · 1 shared paper, 2026 · strength 0.20
  20. Shan Zhang · 1 shared paper, 2026 · strength 0.20
  21. Xueli Zhang · 1 shared paper, 2026 · strength 0.20
  22. Ningning Niu · 1 shared paper, 2026 · strength 0.20
  23. Li-Peng Hu · 1 shared paper, 2026 · strength 0.20
  24. Shuqi Cai · 1 shared paper, 2026 · strength 0.20
  25. Xiaomei Yang · 1 shared paper, 2026 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.